Table of Contents

 
 
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
Date of Report (Date of earliest event reported): December 20, 2007
MEDCATH CORPORATION
(Exact name of registrant as specified in its charter)
         
         
Delaware   000-33009   56-2248952
(State or other jurisdiction of   (Commission File Number)   (IRS Employer Identification No.)
incorporation or organization)        
10720 Sikes Place
Charlotte, North Carolina 28277
(Address of principal executive offices, including zip code)
(704) 708-6600
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
  o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
  o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
  o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
  o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13d-4(c))
 
 
 

 

TABLE OF CONTENTS

Item 7.01. Regulation FD Disclosure
Item 9.01 Financial Statements and Exhibits
SIGNATURES
Exhibit 99.1

Table of Contents

Item 7.01. Regulation FD Disclosure
  MedCath Corporation will host an analyst day in New York City on December 20, 2007. See additional information in the presentation furnished as an exhibit in Item 9.01.
Item 9.01 Financial Statements and Exhibits
         
Exhibit    
No.   Description
       
 
  99.1    
Analyst day presentation.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
         
    MEDCATH CORPORATION
 
  		 
Date: December 20, 2007  By:   /s/ James E. Harris    
    James E. Harris   
    Executive Vice President and Chief Financial Officer  
 

 

Medcath (NASDAQ:MDTH)
Historical Stock Chart
From Jul 2024 to Aug 2024 Click Here for more Medcath Charts.
Medcath (NASDAQ:MDTH)
Historical Stock Chart
From Aug 2023 to Aug 2024 Click Here for more Medcath Charts.